We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about ...

Over the past 15 years, Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products. CRISPR Therapeutics won its first regulatory ...

Vertex Pharmaceuticals (NASDAQ: VRTX) is a great example of biotech success. The company has built a cystic fibrosis (CF) empire, bringing in billions of dollars in revenue annually, and now is ...

John Schneider praised his players multiple times tonight for «playing their asses off» in Boston. Chris Bassitt echoed that, praising the «gritty wins» Bassitt: «As long as we're keeping our team in ...

Shares of Vertex Pharmaceuticals Inc. VRTX slid 1.41% to $475.49 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 3.46% ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $475.49, marking a -1.41% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 3.46%.

In its first quarter 2025 investor letter, GreensKeeper Asset Management emphasized stocks such as Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Vertex Pharmaceuticals Incorporated (NASDAQ ...

City lawyers, department chiefs, and a representative from the Jewish community met with US Department of Justice officials at Boston City Hall Wednesday in advance of a meeting later this month ...

Chris Hall, headteacher of Footsteps Trust, told Sky News it was "quite staggering" that no one in education was consulted about the decision. He said the school-based officers had been "very ...

Shares of Vertex Pharmaceuticals Inc. VRTX rose 2.10% to $482.30 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 9.52% ...

After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation ... Meanwhile, others such as Bristol Myers Squibb’s Chris Boerner (PDF) ($18.8 million ...